ENTITY
Pw Medtech

Pw Medtech (1358 HK)

7
Analysis
Health CareChina
PW Medtech Group Ltd is a medical device developer, manufacturer and marketer in China. The Company's products include infusion products and orthopedic implant products.
more
bearishLepu Biopharma
13 May 2021 09:08

Pre-IPO Lepu Biopharma - There Are Still Many Uncertainties

This article analyzed Lepu Biopharma in terms of its core product candidates in the pipeline, the challenges, concerns and future outlook for this...

Logo
316 Views
Share
02 Mar 2021 13:36

CBPO's Vote Gets Up But Dissenters Lurk

Currently trading at a gross/annualsed spread of 1.5%/7.5%. This assumes payment mid-May if assuming the negotiation process drags out to its full...

Logo
339 Views
Share
20 Nov 2020 15:35

China Biologics (CBPO US): Firm Offer Backed By Prerequisite Votes

Trading at a gross/annualised spread at 4.4%/11.7%.  This looks like a pretty clean deal for around four-five months of work.

Logo
455 Views
Share
18 Jun 2020 20:54

Golden Meditech (801 HK): Prescription Renewal

Back on 13 January 2017, Golden Meditech Holdings Ltd ("GMH", 801 HK) announced an Offer from Kam Yuen, the chairman & controlling shareholder...

Logo
478 Views
Share
bullishLY
29 Nov 2019 13:02

(Mostly) Asia M&A: November 2019 Roundup

For the month of November, 21 new deals were discussed on Smartkarma with an overall announced deal size of ~US$75bn, helped in large part by...

Logo
600 Views
Share
x